Analyst Ratings for MBX Biosciences Inc (MBX)
MBX Rating Summary
MBX Price Target Summary
- Highest: $88.00 (Guggenheim)
- Lowest: $18.00 (Goldman Sachs)
- Average: $65.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$65.10 (+51.3%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$65.10 (+51.3%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2026 | Oppenheimer | Leland Gershell | New Coverage | Outperform (N/A) |
80.00 (N/A) |
29.78 (43.03) |
44.49% | Details |
| 1/28/2026 | Barclays » Updated 5/12/2026 |
Eliana Merle | New Coverage | Overweight (N/A) |
70.00 (66.00) |
36.60 (43.03) |
17.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
